Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	23
Overall Study	STARTED	Pregabalin 50 mg	22
Overall Study	STARTED	Pregabalin 100 mg	23
Overall Study	STARTED	Pregabalin 150 mg	22
Overall Study	STARTED	Pregabalin 300 mg	24
Overall Study	STARTED	Pregabalin 450 mg	23
Overall Study	COMPLETED	Placebo	21
Overall Study	COMPLETED	Pregabalin 50 mg	20
Overall Study	COMPLETED	Pregabalin 100 mg	22
Overall Study	COMPLETED	Pregabalin 150 mg	17
Overall Study	COMPLETED	Pregabalin 300 mg	23
Overall Study	COMPLETED	Pregabalin 450 mg	18
Overall Study	NOT COMPLETED	Placebo	2
Overall Study	NOT COMPLETED	Pregabalin 50 mg	2
Overall Study	NOT COMPLETED	Pregabalin 100 mg	1
Overall Study	NOT COMPLETED	Pregabalin 150 mg	5
Overall Study	NOT COMPLETED	Pregabalin 300 mg	1
Overall Study	NOT COMPLETED	Pregabalin 450 mg	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00676403/flow